Log In / Sign Up Semaglutide is a synthetic GLP-1 receptor agonist for metabolic and endocrine research
June 20, 2023 Novo Nordisk announces intention to sue medical spas, wellness clinics, and medical weight loss practices that improperly market and sell products claiming to contain semaglutide
3* Pharmacological potentiation index for treating viral hepatitis = 100 (therapeutic effects of Al-hijamah + conventional pharmacological treatments)/(therapeutic effects of conventional pharmacological treatments only)
Several compounds synthesized by a healthy liver ( haptoglobin, apolipoprotein-A1, albumin, alpha-2-macroglobulin ) may fall with the onset of liver damage
However, as with any research compound, potential for temporary skin reactions exists, and careful observation is always recommended